Evidence map›Paper›PMID 42188595›Full record

ArticleMicrobiology spectrum2026

Blinded trial of multiplex serodiagnostic test in India for diverse forms of active tuberculosis.

Ritu Singhal, Resmi Ravindran, Sanket Poniya, Lokender Kumar, Vithal P Myneedu, Rohit Sarin, Pankaj Krishna, Ed Goldberg, Stephen J Dunn, Puneet Gupta and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ritu Singhal *Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Resmi Ravindran *Department of Pathology and Laboratory Medicine, University of California, Davis, California, USA.ORCID 0000-0002-3532-0261
Sanket PoniyaNextGen In Vitro Diagnostics, New Delhi, India.
Lokender KumarDepartment of TB and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Vithal P MyneeduDepartment of TB and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Rohit SarinDepartment of TB and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Pankaj KrishnaNextGen In Vitro Diagnostics, New Delhi, India.
Ed GoldbergOptimAES LLC, Los Gatos, California, USA.
Stephen J DunnAppGenex Diagnostics, Inc., Mountain View, California, USA.
Puneet GuptaTropical Animal Genetics Pvt Ltd, Chennai, India.
Scott BornheimerBecton Dickinson, San Jose, California, USA.
Imran H KhanDepartment of Pathology and Laboratory Medicine, University of California, Davis, California, USA.ORCID 0000-0003-3315-1967

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid, high-throughput, and point-of-care tests to detect diverse major forms of active tuberculosis (TB) are urgently needed. Our blood test can fulfill that need. The blinded trial of the multiplex serodiagnostic test in India described here builds on our previously published field studies in diverse endemic regions (India, Uganda, and Pakistan). Antibody responses to

Indexed as

Mycobacterium tuberculosisSerologic TestsTuberculosisAdolescentAdultAntibodies, BacterialAntigens, BacterialChildFemaleHumansIndiaMaleRapid Diagnostic TestsSensitivity and SpecificityTuberculosis, ExtrapulmonaryTuberculosis, PulmonaryAntibodies, BacterialAntigens, Bacterialantibody profilingbiomarkersserodiagnosistuberculosis

Identifiers

PMID42188595
PMCPMC13339956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.